Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Alcon Launches PRECISION7 One-Week Contact Lens
Alcon has announced the U.S. launch of PRECISION7, a groundbreaking contact lens designed for a convenient one-week replacement cycle. Incorporating the advanced 7-day ACTIV-FLO system, these lenses offer up to 16 hours of comfort and clear vision, even on the…
Global track for residents: International education, bidirectional impact – Mayo Clinic
Global track for residents: International education, bidirectional impact Mayo Clinic Source: Author: | Date: 2024-10-30 07:00:00 Source: Author: | Date: 2024-10-30 07:00:00
Osheru Receives Funding for Ziplyft Device for Blepharoplasty
Osheru announced the successful completion of a $4.7 million funding round aimed at accelerating the development and commercialization of its Ziplyft device for blepharoplasty surgery. The funding round was oversubscribed and led by a consortium of investors including individuals, family…
New Research Unveils Uveal Melanoma Metastasis Mechanisms
New research from Edith Cowan University (ECU) is shedding light on the factors driving the metastasis of uveal melanoma, the deadliest form of eye cancer known for its high rate of spreading to the liver. Uveal Melanoma Overview and Metastasis…
Samsara Vision Launches SING IMT in China
Samsara Vision announced the successful completion of the first SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) procedure in China. This milestone was achieved at the First Affiliated Hospital of Hainan Medical University Lecheng Hospital, where Professor Li Xiaorong, MD, PhD,…
Topcon and Orbis Partner to Expand DR Screening in Rwanda
Topcon Healthcare, in collaboration with Orbis International and the Rwanda International Institute of Ophthalmology (RIIO), has embarked on an initiative to enhance diabetic retinopathy screening in Rwanda. Donation of Robotic Retinal Cameras To facilitate this effort, Topcon has generously donated…
Okyo Pharma’s Phase 2 Trial for Neuropathic Corneal Pain
Okyo Pharma announced its plan to initiate a phase 2 clinical trial for OK-101 in the treatment of neuropathic corneal pain (NCP), scheduled to begin in the third quarter of 2024. This one-year study follows promising results from preclinical animal…
ENTOD Pharma Introduces New Eye Drop Preservative System
Mumbai-based ENTOD Pharmaceuticals has unveiled a novel advancement in ophthalmic care with the introduction of EyeBS, a new eye drop preservative system. EyeBS is specifically designed to supplant traditional detergent-based preservatives such as Benzalkonium Chloride (BAK) and Polyquaternium-1, offering a…
Researchers Discover New Imaging Technique for MS Diagnosis
Researchers from Durham University, UK, and Isfahan University of Medical Sciences, Iran, have discovered a pioneering method for diagnosing multiple sclerosis (MS) using advanced eye imaging techniques. Published in the journal Translational Vision Science & Technology, their work introduces a…
Ophthalmologic Manifestations of Acute Leukemia Are Detectable
Acute leukemia can present with various ophthalmologic manifestations, which are detectable at both initial presentation and relapse, according to a study published online on July 10 in the Annals of Hematology. Dr. Dina N. Laimon and her colleagues from Mansoura…